| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Common Stock | Options Exercise | $1,670,604 | +72,984 | +54% | $22.89 | 209,179 | 25 Feb 2023 | Direct | F1 |
| transaction | PFE | Common Stock | Tax liability | $935,743 | -22,413 | -11% | $41.75 | 186,766 | 25 Feb 2023 | Direct | F2, F3 |
| transaction | PFE | Common Stock | Tax liability | $1,409,845 | -32,455 | -17% | $43.44 | 154,311 | 25 Feb 2023 | Direct | F4, F5 |
| holding | PFE | Common Stock | 772 | 25 Feb 2023 | By Rule 16b-3 Plan |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PFE | Stock Appreciation Rights | Options Exercise | $0 | -72,984 | -100% | $0.000000* | 0 | 25 Feb 2023 | Common Stock | 72,984 | $22.89 | Direct |
| Id | Content |
|---|---|
| F1 | The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F2 | The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. |
| F3 | Price is the closing price of Pfizer common stock on February 24, 2023. |
| F4 | The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). |
| F5 | Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. |